Direct-Acting Oral Anticoagulants (DOAC) Score
Predicts bleeding risk in patients with atrial fibrillation on DOAC.
Advice
- The decision to use anticoagulation therapy with a DOAC should consider multiple factors. This tool should not be the sole determinant of treatment planning, but should guide shared decision-making between the patient and clinician.
- A high score is not necessarily a contraindication to DOAC therapy; clinical context is key.
- Where possible, efforts should be made to address modifiable risk factors for bleeding.